BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Paré L, Altés A, Cajal TRY, Del Rio E, Alonso C, Sedano L, Barnadas A, Baiget M. Influence of thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms on the disease-free survival of breast cancer patients receiving adjuvant 5-fluorouracil/methotrexate-based therapy. Anti-Cancer Drugs 2007;18:821-5. [DOI: 10.1097/cad.0b013e3280b10d23] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhao T, Gu D, Xu Z, Huo X, Shen L, Wang C, Tang Y, Wu P, He J, Gong W, He ML, Chen J. Polymorphism in one-carbon metabolism pathway affects survival of gastric cancer patients: Large and comprehensive study. Oncotarget 2015;6:9564-76. [PMID: 25840420 DOI: 10.18632/oncotarget.3259] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
2 Brooks JD, Teraoka SN, Bernstein L, Mellemkjær L, Malone KE, Lynch CF, Haile RW, Concannon P, Reiner AS, Duggan DJ, Schiermeyer K, Bernstein JL, Figueiredo JC; WECARE Study Collaborative Group. Common variants in genes coding for chemotherapy metabolizing enzymes, transporters, and targets: a case-control study of contralateral breast cancer risk in the WECARE Study. Cancer Causes Control 2013;24:1605-14. [PMID: 23775025 DOI: 10.1007/s10552-013-0237-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
3 Rofaiel S, Muo EN, Mousa SA. Pharmacogenetics in breast cancer: steps toward personalized medicine in breast cancer management. Pharmgenomics Pers Med 2010;3:129-43. [PMID: 23226048 DOI: 10.2147/PGPM.S10789] [Cited by in F6Publishing: 1] [Reference Citation Analysis]